'scuse the ignorance but I'm a little late to the MVP train and I have something I'd like cleared up regarding pending Penthrox approval in the US.
MethoxyFlurane was withdrawn from sale in 2005 by the FDA on a number of counts, mainly safety and effectiveness, according to the below link:
https://www.fda.gov/ohrms/dockets/98fr/05-17559.htm
What makes MVP's current application different?
cheers
Dmarc
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
67.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $76.04M | |||
| Open | High | Low | Value | Volume |
| 68.0¢ | 69.0¢ | 66.5¢ | $138.8K | 203.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14989 | 67.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 69.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 18/09/2025 (20 minute delay) ? |
| MVP (ASX) Chart |